Zymeworks Inc. (ZYME)
NASDAQ: ZYME · Real-Time Price · USD
23.60
-0.42 (-1.75%)
Mar 24, 2026, 4:00 PM EDT - Market closed
Zymeworks Employees
Zymeworks had 264 employees as of December 31, 2025. The number of employees decreased by 22 or -7.69% compared to the previous year.
Employees
264
Change (1Y)
-22
Growth (1Y)
-7.69%
Revenue / Employee
$401,383
Profits / Employee
-$307,311
Market Cap
1.74B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 264 | -22 | -7.69% | 264 | 0 |
| Dec 31, 2024 | 286 | 8 | 2.88% | 280 | 6 |
| Dec 31, 2023 | 278 | -16 | -5.44% | 272 | 6 |
| Dec 31, 2022 | 294 | -164 | -35.81% | 291 | 3 |
| Dec 31, 2021 | 458 | 103 | 29.01% | 455 | 3 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Ultragenyx Pharmaceutical | 1,371 |
| Sarepta Therapeutics | 835 |
| Recursion Pharmaceuticals | 600 |
| Agios Pharmaceuticals | 540 |
| Vericel | 398 |
| Ocular Therapeutix | 325 |
| Capricor Therapeutics | 231 |
| Relay Therapeutics | 192 |
ZYME News
- 15 hours ago - Zymeworks Announces Participation in Upcoming Investor Conferences - GlobeNewsWire
- 6 days ago - Zymeworks Announces Presentations for Ziihera® (zanidatamab-hrii) at 2026 AACR Annual Meeting - GlobeNewsWire
- 7 days ago - Zymeworks to Present Clinical and Preclinical Data on ADC Programs Including Novel RAS ADC Platform at AACR Annual Meeting - GlobeNewsWire
- 20 days ago - Zymeworks FY25 Review: From Milestone Volatility To 2026 Upside - Seeking Alpha
- 21 days ago - Zymeworks Inc. (ZYME) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 22 days ago - Zymeworks and Royalty Pharma Enter into $250 Million Royalty-Backed Note Financing - GlobeNewsWire
- 22 days ago - Zymeworks Provides Corporate Update and Reports Fourth Quarter and Full Year 2025 Financial Results - GlobeNewsWire
- 5 weeks ago - Zymeworks To Report Fourth Quarter and Full Year 2025 Financial Results and Host Conference Call on March 2, 2026 - GlobeNewsWire